Understanding how cells migrate

15-Nov-2010 - USA

Migration of cells in response to chemicals in the external environment is vital for the correct functioning of all life from bacteria to multi-cellular organisms. Understanding the mechanisms involved is central to studies of normal development as well as disease states like cancer. This special issue of the journal Integrative biology highlights the contributions of novel tools and technologies to this important field.

A broad spectrum of technology and biology is included: topics covered include neutrophil and Dictyostelium chemotaxis, mechanobiology, amoeboid migration and the application of microfluidics to the study of directed cell migration. Technology for in vivo studies and improved methods for studying axon guidance are also included. Finally, the role of chemotaxis in cancer is examined.

“The integration of technology and biology has matured further here than in many other areas of biological study” says David Beebe from the University of Wisconsin-Madison’s department of biomedical engineering. “The papers in this issue highlight advances in technology that allow investigators to address fundamental questions about directed migration that provide insight into basic mechanisms and provide tools for drug discovery and clinical intervention” he added.

Original publication: David J. Beebe and Anna Huttenlocher, Integr. Biol., 2010, 2, 559-560.

Other news from the department science

Most read news

More news from our other portals

Last viewed contents

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New approach in the treatment of non-alcoholic fatty liver disease - Resistant starch, such as that found in green bananas, may play an important role in treatment of non-alcoholic fatty liver disease in the future

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

New model could revolutionise the treatment of autoimmune disease as well as vaccine development - Paradigm shift in immunology: 'Adaptive Tolerance' balances autoimmune reaction

Successful Outcome from European Clinical Pharmacokinetic Study Comparing SUBA-Itraconazole with Sporanox - HalcyGen to begin Marketing Authorisation Application for Regulators in Europe

Evotec Receives a Milestone Payment as Part of its Discovery Alliance with Boehringer Ingelheim

UF study strengthens concerns about long-term use of certain painkillers

Scientists at Almac and Queen’s University Belfast discover novel approach to treat cancer patients.

Restoring chemotherapy sensitivity by boosting microRNA levels

Restoring chemotherapy sensitivity by boosting microRNA levels

Bayer and Onyx Initiate Phase III Trial of Nexavar in Patients with Non-Responsive Thyroid Cancer

Centocor, Inc. - Horsham, USA

Centocor, Inc. - Horsham, USA

Advanced Cell Technology Announces Creation of Human Embryonic Stem Cell Lines Without the Destruction of Embryos - Breakthrough Approach Improves Efficiency to Levels Reported in the Conventional Stem Cell Derivation Techniques

Generex Biotechnology and Pevion Biotech announce plans for immunotherapeutic vaccine collaboration

Inex Pharmaceuticals Announces Appeal Date for Spin-out of Tekmira Pharmaceuticals